Kavar Capital Partners Group, LLC Merck & Co., Inc. Transaction History

Kavar Capital Partners Group, LLC

$630 Million
Q3 2024

A detailed history of Kavar Capital Partners Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 17,151 shares of MRK stock, worth $1.69 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

17,151

Previous 17,299 0.86%

Holding current value

$1.69 Million

Previous $2.14 Million 9.06%

% of portfolio

0.31%

Previous 0.39%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$111.15 - $128.97 $16,450 - $19,087	-148 Reduced 0.86%	17,151 $1.95 Million
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $4,952 - $5,318	-40 Reduced 0.23%	17,299 $2.14 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $1.08 Million - $1.26 Million	-9,523 Reduced 35.45%	17,339 $2.29 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $1.22 Million - $1.33 Million	12,173 Added 82.87%	26,862 $2.93 Million
Q3 2023 Nov 06, 2023	SELL	$102.95 - $114.33 $36,444 - $40,472	-354 Reduced 2.35%	14,689 $1.51 Million
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $434 - $473	-4 Reduced 0.03%	15,043 $1.74 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $15,132 - $16,884	-147 Reduced 0.97%	15,047 $1.6 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $77,646 - $99,553	-888 Reduced 5.52%	15,194 $1.69 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $96,955 - $108,919	-1,147 Reduced 6.66%	16,082 $1.39 Million
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $10,686 - $12,113	128 Added 0.75%	17,229 $1.57 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $1,837 - $2,060	25 Added 0.15%	17,101 $1.4 Million
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $40,838 - $51,155	-565 Reduced 3.2%	17,076 $1.31 Million
Q3 2021 Nov 01, 2021	BUY	$71.68 - $78.83 $19,712 - $21,678	275 Added 1.58%	17,641 $1.33 Million
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $31,639 - $34,996	-450 Reduced 2.53%	17,366 $1.35 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $234,124 - $275,774	3,400 Added 23.58%	17,816 $1.37 Million
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $1.03 Million - $1.15 Million	14,416 New	14,416 $1.18 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Account

Kavar Capital Partners Group, LLC Merck & Co., Inc. Transaction History